# US 2025/0208142 A1 · Rapid detection method for abrin toxin

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0208142 A1
- Document ID: US20250208142A1
- Status: Published application
- Kind: A1
- Application number: 18/882,795
- Filed: 2024-09-12
- Published: 2025-06-26
- Earliest claimed: 2023-12-26
- Assignees: Academy of Military Medicine, PLA Academy of Military Sciences
- Applicants: Academy of Military Medical Sciences
- Inventors: Wenwen XIN; Lin KANG; Jiaxin LI; Tingting LIU; Lina DONG; Shan GAO; Jinglin WANG
- Web page: https://patentgrep.com/patent/US20250208142A1

## CPC

- G01N 33/68: involving proteins, peptides or amino acids {(involving lipoproteins G01N33/92)}
- G01N 21/6428: {Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" (in vivo A61B5/00; immunoassay G01N33/53)}
- G01N 33/5308: {for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites}
- G01N 33/54326: {Magnetic particles}
- G01N 33/582: {with fluorescent label}
- G01N 2021/6439: {with indicators, stains, dyes, tags, labels, marks}
- G01N 2333/42: Lectins, e.g. concanavalin, phytohaemagglutinin
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

A rapid detection method for abrin toxin is provided. The rapid detection method for abrin toxin includes the following steps: reacting an oligonucleotide chain substrate labeled with a fluorescent group and a quenching group, a buffer solution, a BSA solution, a to-be-detected sample and sterile water, incubating at a constant temperature, detecting a fluorescence signal value, and determining whether the abrin toxin exists based on a difference between a change in final fluorescence signal value and a change in final fluorescence signal value of a negative control; where the sample is judged as a positive sample when an average value of the detected final fluorescence signal values is greater than an average value of the final fluorescence signal values of the negative control by +3 times standard deviation. According to the detection method, the direct addition of the sample into the reaction system can reach the sensitivity of 30 ng/mL.

## Claims

### Claim 1

A rapid detection method for abrin toxin, comprising the following steps:
subjecting an adenine-containing oligonucleotide chain substrate labeled with a fluorescein (FAM) fluorescent group and a Black Hole Quencher 1 (BHQ1) quenching group, a buffer solution, a bovine serum albumin (BSA) solution, a to-be-detected sample, and sterile water to a reaction to obtain a product,
incubating the product at a constant temperature to obtain an incubated product,
detecting a fluorescence signal value 2-5 times to obtain final fluorescence signal values of the incubated product, and
determining whether the abrin toxin exists based on a difference between an average value of final fluorescence signal values of the incubated product and final fluorescence signal value of a negative control; wherein
the buffer solution is an ammonium formate buffer solution, an ammonium acetate buffer solution, an ammonium citrate buffer solution, an ammonium acetate and ethylene diamine tetraacetic acid (EDTA) buffer solution, or an ammonium citrate and EDTA buffer solution;
the to-be-detected sample is enriched by using antibody-coated magnetic beads, wherein antibodies for coating the magnetic beads are specific for abrin toxin; and
the negative control is sterile water.

### Claim 2 (depends on 1)

The rapid detection method according to claim 1, wherein an amount of the adenine-containing oligonucleotide chain substrate labeled with the FAM fluorescent group and the BHQ1 quenching group, the buffer solution, the BSA solution, the to-be-detected sample, and the sterile water is 0.5-6 μL, respectively.

### Claim 3 (depends on 1)

The rapid detection method according to claim 1, wherein an amount of the antibodies for coating the magnetic beads is 20-30 μg per 0.5-2 mg of the magnetic beads.

### Claim 4

(canceled)

### Claim 5 (depends on 1)

The rapid detection method according to claim 1, wherein the adenine-containing oligonucleotide chain substrate labeled with the FAM fluorescent group and the BHQ1 quenching group has a final concentration of 2-20 μM; the ammonium formate buffer solution, the ammonium acetate buffer solution, and the ammonium citrate buffer solution have a final concentration of 0.2-20 mM, respectively; in the ammonium acetate and EDTA buffer solution, ammonium acetate has a final concentration of 0.2-20 mM, and EDTA has a final concentration of 0.2-0.8 mM; in the ammonium citrate and EDTA buffer solution, ammonium citrate has a final concentration of 0.2-20 mM, and EDTA has a final concentration of 0.2-0.8 mM; and the BSA solution has a final concentration of 10-100 μg/mL.

### Claim 6 (depends on 1)

The rapid detection method according to claim 1, wherein the reaction is performed at a pH value of 3.5-4.8 and a temperature of 40-75° C. for 30-50 min.

### Claim 7

(canceled)

### Claim 8 (depends on 1)

The rapid detection method according to claim 1, wherein the to-be-detected sample is judged as a positive sample when the average value of the final fluorescence signal values of the incubated product is greater than the final fluorescence signal value of the negative control by plus 3 times standard deviation.
